Crispr Therapeutics AG vs LTC Properties Inc — how do they compare? Crispr Therapeutics AG trades at $53.88 (market cap $5.23B), while LTC Properties Inc trades at $38.12 (market cap $2.05B). The key difference: Crispr Therapeutics AG is far larger — about 2.6× LTC Properties Inc's market cap, and LTC Properties Inc pays a 5.98% dividend while Crispr Therapeutics AG pays none. Which is the better fit depends on your goals.
| CRSP | LTC | |
|---|---|---|
Market Cap | $5.23B | $2.05B |
Sector | Health | Real Estate |
52-Week High | $76.78 | $42.81 |
52-Week Low | $44.34 | $33.98 |
Enterprise Value | $3.65B | $2.79B |
Dividend Yield | — | 5.98% |
Trailing returns across standard periods
CRISPR Therapeutics is a gene editing company focused on the development of CRISPR/Cas9-based therapeutics. CRISPR/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. CRISPR's most advanced pipeline candidate, CTX001, is in collaboration with Vertex Pharmaceuticals and targets sickle cell disease and transfusion-dependent beta-thalassemia, which have high unmet medical needs. The company is progressing additional gene editing programs for immuno-oncology, as well as a stem cell-derived therapy for the treatment of Type 1 diabetes.
Read more on CRSP →LTC Properties Inc is a healthcare facility real estate investment trust. The company operates one segment that works to invest in healthcare facilities through mortgage loans, property lease transactions, and other investments. LTC generates all of its revenue in the United States. LTC is an active capital provider in the seniors housing and health care real estate industry. The company has been actively engaged with its operating partners to create a growing pipeline of projects. LTC considers merger and acquisition investment as a component of its operational growth strategy.
Read more on LTC →